STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results

Go back to STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results

Jefferies Downgrades STAAR Surgical (STAA) to Hold

February 12, 2025 11:07 AM EST

Jefferies analyst Raj Denhoy downgraded STAAR Surgical (NASDAQ: STAA) from Hold to Hold with a price target of $18.00 (from $60.00).

The analyst comments "We are downgrading STAA to Hold, following its 4Q24 results and initial 2025E guidance which reflects a... More

STAAR Surgical (STAA) PT Lowered to $20 at Stifel

February 12, 2025 6:01 AM EST

Stifel analyst Thomas M. Stephan lowered the price target on STAAR Surgical (NASDAQ: STAA) to $20.00 (from $38.00) while maintaining a Buy rating.

The analyst comments "STAA shares have faced pressure over the last several quarters from a deteriorating China macroeconomic environment, but... More